COMMUNIQUÉS West-GlobeNewswire

GENFIT : GENFIT et Terns Pharmaceuticals annoncent un partenariat stratégique de 228MM$ pour le développement et la commercialisation d’elafibranor en Chine
24/06/2019
GENFIT et Terns Pharmaceuticals annoncent un partenariat stratégique de 228MM$ pour le développement et la commercialisation d’elafibranor en Chine Lille (France), Cambridge (Massachusetts, États-Unis), le 24 juin 2019 [...]
Conatus to Explore Strategic Alternatives and Implement Restructuring Plan
24/06/2019
SAN DIEGO, June 24, 2019 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced that the company has engaged Oppenheimer & Co., Inc., as its financial advisor to assist in the exploration and [...]
Conatus Announces Results from ENCORE-LF and ENCORE-PH Phase 2b Clinical Trials in NASH Cirrhosis
24/06/2019
SAN DIEGO, June 24, 2019 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced that top-line results from the company’s ENCORE-LF clinical trial of emricasan did not meet its primary endpoint [...]
Nabriva Therapeutics Announces European Medicines Agency (EMA) Validation of Marketing Authorization Application for Lefamulin
24/06/2019
DUBLIN, Ireland, June 24, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a clinical-stage biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious [...]
Eloxx Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
24/06/2019
WALTHAM, Mass., June 24, 2019 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (“Eloxx”) (Nasdaq: ELOX) today announced the closing of its underwritten public offering of 3,833,334 shares of its common stock, which [...]
Cytokinetics Announces Preclinical Data for Reldesemtiv to be Presented at the 2019 Annual Cure SMA Conference
24/06/2019
SOUTH SAN FRANCISCO, Calif., June 24, 2019 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq:CYTK) today announced that two preclinical poster presentations on the addition of reldesemtiv to treatment with SMN [...]
Immutep to Host Key Opinion Leader Call
24/06/2019
Presentations on Novel Immuno-Oncology Therapy (eftilagimod alpha) in Metastatic Breast Cancer and Other Settings NEW YORK, June 24, 2019 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the [...]
Vital® to focus on Enterprise Imaging and Encounters-Based Imaging Workflow Experience at SIIM 2019
24/06/2019
MINNETONKA, Minn., June 24, 2019 (GLOBE NEWSWIRE) -- At this year's Society for Imaging Informatics in Medicine (SIIM) Annual Meeting, Vital will highlight Enterprise Imaging and how Encounters-Based Imaging Workflow [...]
Stryker to host conference call on July 25, 2019
24/06/2019
Kalamazoo, Michigan, June 24, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will host a conference call on Thursday, July 25, 2019 at 4:30 p.m., Eastern Time, to discuss the Company's operating results [...]
QR Pharma Adopts new Corporate Name: Annovis Bio
24/06/2019
Change reflects enhanced focus on neurodegenerative diseases BERWYN, Pa., June 24, 2019 (GLOBE NEWSWIRE) -- QR Pharma, Inc., a biopharmaceutical company developing novel therapies for the treatment of Alzheimer’s, [...]
Nova Leap Health Corp. Announces Execution of Definitive Agreement to Acquire Home Care Business in South Central U.S.
24/06/2019
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN HALIFAX, Nova Scotia, June 24, 2019 (GLOBE NEWSWIRE) -- NOVA [...]
DNV3681's exceptional activity against bioterrorist threats presented at ASM Microbe 2019
24/06/2019
DNV3681's exceptional activity against bioterrorist threats presented at ASM Microbe 2019 Major Steven Zumbrun (USAMRIID 1 , U.S. Department of Defense) presented data on the in vitro assessment of DNV3681 against [...]
L’activité exceptionnelle du DNV3681 contre des menaces bioterroristes présentée à l’ASM Microbe 2019
24/06/2019
L’activité exceptionnelle du DNV3681 contre des menaces bioterroristes présentée à l’ASM Microbe 2019 Le Major Steven Zumbrun (USAMRIID 1 , Département de la Défense des Etats-Unis) a présenté la semaine dernière à San [...]
Transactions in relation to share buyback program
24/06/2019
Announcement no. 38/2019 24 June 2019 Transactions in relation to share buyback program On 14 May 2019, Össur hf. initiated a share buy-back program, see Company announcement no. 31/2019. The purpose of the share [...]
Kiadis Pharma Announces Results Annual General Meeting
24/06/2019
Kiadis Pharma Announces Results Annual General Meeting Amsterdam, The Netherlands, June 24, 2019 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS), a clinical stage [...]
SPINEWAY : Congrès annuel de la chirurgie du rachis de Strasbourg et premières pierres du rapprochement avec NCC
24/06/2019
Présentation de la gamme Mont-Blanc MIS au congrès annuel de la chirurgie du rachis de Strasbourg Premières pierres du rapprochement avec NCC (Colombie) Spineway a participé au congrès annuel de la Société Française de [...]
Oxford Immunotec Appoints Patrick J. Balthrop, Sr. as Chairman
24/06/2019
OXFORD, United Kingdom and MARLBOROUGH, Mass., June 24, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced that it has [...]
Konica Minolta Healthcare and the Emory Healthcare Innovation Hub Partner to Drive Innovation in Healthcare
24/06/2019
WAYNE, N.J., June 24, 2019 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc. and the Emory Healthcare Innovation Hub recently formed a strategic partnership that aims to positively impact healthcare in the U. [...]
BioHemp International, Inc (OTC: BKIT) Appoints Ryan Fishoff as Lead Advisor to Company to Assist With CBD Distribution Consolidation Focus
24/06/2019
The ‘King of CBD’ joins the Company as an advisor to help lead its rollup strategy. NEW YORK, June 24, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE – BioHemp International, Inc. (OTC: BKIT), (“Company”) announces that it [...]

Pages